CN Stock MarketDetailed Quotes

000627 Hubei Biocause Pharmaceutical

Watchlist
  • 5.07
  • +0.21+4.32%
Market Closed Dec 16 15:00 CST
25.05BMarket Cap-32.50P/E (TTM)

Hubei Biocause Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hubei Biocause Pharmaceutical Q3 2024 Earnings Date

Currency：CNYOct 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
4.54B
--
-41.49%
EPS
--
<0.01
--
--
Analyst Rating
No Data

Hubei Biocause Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

No Data

Hubei Biocause Pharmaceutical Earnings Reports

  • Tianmao Group: Report for the third quarter of 2024

    Oct 31 00:00

  • Tianmao Group: Tianmao Group\'s performance forecast for the first three quarters of 2024

    Oct 15 00:00

  • Tianmao Group: Guohua Life 2024 Semi-Annual Report

    Aug 31 00:00

  • Tianmao Group: 2024 Semi-Annual Report Summary

    Aug 31 00:00

    • Read more

    Top CN Stock Gainers
    Symbol Price % Chg
    TAIHUSNOW CO.,LTD.
    838262
    33.86 +25.18%
    Guangdong Brandmax Marketing
    300805
    13.42 +20.04%
    Guangdong Transtek Medical Electronics
    300562
    17.32 +20.03%
    Suzhou Kingswood Education Technology
    300192
    18.40 +20.03%
    Broadex Technologies
    300548
    28.36 +20.02%

    See the daily top gainer.

    Investment Theme MSCI concept
    MSCI concept
    Intraday-0.21%
    Transferring Securities of Securities
    Transferring Securities of Securities
    Intraday-0.31%
    Finance and Securities Lending
    Finance and Securities Lending
    Intraday-0.31%